What is the Projected CAGR value of the Syndromic Multiplex Diagnostic Market?
The Syndromic Multiplex Diagnostic Market is expected to grow at a high CAGR of 7.3% during 2023-2030.
Who are the key players contributing to the growth of Syndromic Multiplex Diagnostic Market?
Some of the major key players in the global syndromic multiplex diagnostic market are Biomerieux SA, Luminex Corporation, QIAGEN, Applied BioCode, Akonni Biosystems, Abbott Diagnostics,
Which region will be controlling the global Syndromic Multiplex Diagnostic market during 2023-2030?
North America region Controls the Syndromic Multiplex Diagnostic during 2023-2030.
Which segment holds the highest market share?
Respiratory Syndrome holds the largest share in the global syndromic multiplex diagnostic market